Aperture Venture Partners is a private equity general partner firm headquartered in New York, NY, United States.
Biohaven Pharmaceutical Holding Company has closed the second tranche of its $80m private placement from Venrock and others.
Biohaven Pharmaceutical Holding Company, a US-based biopharmaceutical company, completed an $80m vc funding led by Venrock.
Spirox, a medical device company, closed a $45m Series C round from KKR, HealthQuest Capital, Aisling Capital, Venrock and others.
Read more news concerning Aperture Venture Partners
A sampling of Aperture Venture Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?